Overview

N-acetylcysteine in the Treatment of PTSD and Addiction

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Examine the effects of N-acetylcysteine on PTSD symptoms, craving and substance use in veterans with PTSD and comorbid substance use disorders.
Phase:
Phase 2
Details
Lead Sponsor:
Medical University of South Carolina
Treatments:
Acetylcysteine
N-monoacetylcystine